CClinicalTrials.gg
CompletedNCT03370393Updated Jan 26, 2026Results posted

Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects

An interventional study of Pathways for African-Americans' Success (PAAS) in Risk-Taking and Adolescent Behavior, sponsored by University of California, Irvine. Completed at 1 site in United States. Open to participants aged 11 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-26.

Sponsored by University of California, Irvine · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
146
Allocation
Randomized
Ages
11 Years to 14 Years
Sex
All
01

Study summary

Adolescence is a time of biological and behavioral changes that can lead to risky and dangerous behaviors, and African-American youth are highly vulnerable to the consequences of risky behavior, including HIV/AIDS and violence, leading to premature death. The investigators previously showed that an intervention program reduces HIV-risk vulnerability behaviors in many African-American youth. The investigators aim to measure how the program affects different regions of the brain in order to better prevent or reduce such risky behaviors among African-American youth.

Read the detailed description

Adolescence is a time of dramatic biological, behavioral and social changes. It is one of the healthiest periods of the life-span, yet morbidity and mortality rates increase 200%, often attributed to natural tendencies to explore and take risks that increase vulnerability to risky and dangerous behaviors. Rapid advances in developmental neuroscience are revealing new insights into how biology and social context interact to increase adolescents' risk-taking behavior which is attributed to a temporal disassociation between maturational changes in two distinct neural systems: "socio-emotional" (reward) and "cognitive-control" (self-regulation). The socio-emotional system is stimulated by a rapid increase in dopaminergic activity at puberty, which influences reward-seeking behavior. This increase in reward-seeking precedes the maturation of the cognitive-control system and its connections to the reward system. This proposal aims to apply these new insights on neurobiology of adolescents' responses to alcohol/drug use and sex-related risk opportunities by examining brain changes in response to a theoretically-based and empirically-tested prevention program that targets risky behavior in African-American youth during pubertal transition. This racial group is disproportionately affected by the high morbidity and mortality associated with HIV-related risky behaviors and exemplifies a significant health disparity in our society. The intervention was designed on the basis of developmental issues and socio-cultural contextual processes germane to African-American families, and has been shown in randomized controlled trials to delay/deter HIV-related risky behaviors in this vulnerable population. This proposal extends the efficacy studies of the intervention by using functional magnetic resonance imaging to quantify the biological changes in response to the intervention. Identifying neural substrates of the intervention can facilitate refinement of the program by focusing on the components that are most effective in changing behavioral and neural circuitry and also aid in the development of new interventions for subgroups of youth that don't have a positive outcome. Using a randomized controlled design, the investigators will assess the neural substrates of risk-taking and risk-avoidant behavior before and after the 6-week computer-interactive, family-based intervention in 11-13 year-old African-American youth. Psychological processes shown to mediate the intervention effects on behaviors that dissuade alcohol and drug use and sexual onset (i.e. reward-drive and cognitive-emotional self-regulation) will be assessed at baseline and 3 months post-intervention. Based on prior studies that reported observable brain changes in response to psychosocial interventions, the investigators' hypothesis is that a positive response to the intervention will be associated with greater functional connectivity changes between the socio-emotional (reward-drive) and cognitive-control (self-regulation) components of the neural circuitry compared to the control condition, both at rest and during task-performance. They also postulate that these neural changes will mediate the intervention's positive effects on psychological processes involved in youth's decision to avoid HIV-risk vulnerability behaviors in the service of long-term personal goals and positive health outcomes.

02

Conditions studied

  • Risk-Taking
  • Adolescent Behavior

Keywords

  • Reward-drive
  • Cognitive-control
03

Who can participate

Ages eligible
11 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subject is of African-American racial status (self-reported)
  • Subject can speak and read English
  • Subject and parent/legal guardian agree to participate in the 6-week PAAS program
  • Subject and parent/legal guardian agree to complete all assessments
  • Subject must meet MRI safety eligibility

Exclusion criteria

Exclusion Criteria:

  • Subject has a major medical problem (e.g. neurological disorders)
  • Subject is on medication(s) that affects the central nervous system
  • Subject has behavioral/emotional problems at a clinical level (parent and/or youth report)
  • Subject is pregnant or suspected of being pregnant (based on pregnancy test)
  • Subject is color-blind
  • Subject has claustrophobia
  • Subject has metallic implants
  • Subject drinks alcohol in the week prior to entry into the study (based on urine drug screen)
  • Subject uses drugs in the week prior to entry into the study (based on urine drug screen)
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
146 participants (actual)

Study arms

  • Experimental
    Pathways for African-Americans' Success

    Subjects will complete a 6-week Pathways for African-Americans' Success (PAAS) intervention. This is a weekly, 1.5 hour/session, family intervention for 6 weeks.

    Behavioral: Pathways for African-Americans' Success (PAAS)

  • No intervention
    Wait-list

    Subjects will be on waiting list for active intervention and will receive the PAAS intervention at the end of the study (same as active intervention).

Interventions

  • BehavioralPathways for African-Americans' Success (PAAS)

    PAAS is a 6-week, technology-delivered, family-based youth risk intervention program. PAAS includes 6 sessions for parents and youth, and joint sessions in which they both engage on the same computer to integrate and practice the skills they have just learned in their separate sessions. Each session includes a review, a virtual discussion, and observing and interacting with four parent and four youth Avatars that reflect phenotypes of African Americans (AA), with voice-overs by AA parents and youth. Videos portraying family interactions and intrapersonal processes are integrated into each session to convey key points of the intervention along with interactive activities to promote skill-building and to reinforce learning. PAAS also includes a technology tutorial and an introductory session.

05

What researchers measure

Primary outcomes

  1. Changes in Emotional Regulation

    Emotional regulation was assessed through parent and youth self-reported questionnaires using the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2). T scores, normed for age and sex are available. T-score standardizes an individual's executive functioning difficulties relative to peers. For example, 50 is the population mean and a standard deviation of 10. Higher scores indicate more significant problems. Scores below 60 are within normal limits; 60-64: subclinical difficulties; 65-69: mildly elevated; 70-74: moderately elevated; and 75 or above: considered highly elevated, suggesting significant difficulties in emotion regulation. These questionnaires were administered at baseline (before intervention) and 3 months post-intervention. Because parent report may be less biased regarding youth's regulation, we used parent data for analysis. Data imputation was done for missing data.

    Time frame: 18 weeks (from pre-intervention to 3-months after post-intervention)

Secondary outcomes

  1. Changes in Cognitive Regulation

    Cognitive regulation was assessed through parent and youth self-reported questionnaires using the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2). T scores, normed for age and sex are available. T-score standardizes an individual's executive functioning difficulties relative to peers. For example, 50 is the population mean and a standard deviation of 10. Higher scores indicate more significant problems. Scores below 60 are within normal limits; 60-64: subclinical difficulties; 65-69: mildly elevated; 70-74: moderately elevated; and 75 or above: considered highly elevated, suggesting significant difficulties in cognitive regulation. These questionnaires were administered at baseline (before intervention) and 3 months post-intervention. Because parent report may be less biased regarding youth's regulation, we used parent data for analysis. Data imputation was done for missing data.

    Time frame: 18 weeks (from pre-intervention to 3-months after post-intervention)

06

Results

Posted Jan 26, 2026
Limitations and caveats
Trial was completed successfully.

Participant flow

Participant flow — Overall Study
MilestonePathways for African-Americans' SuccessWait-list
Started8660
Completed7150
Not completed1510
Withdrew: Lost to follow-up1510

Outcome measures

PrimaryChanges in Emotional Regulation

Emotional regulation was assessed through parent and youth self-reported questionnaires using the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2). T scores, normed for age and sex are available. T-score standardizes an individual's executive functioning difficulties relative to peers. For example, 50 is the population mean and a standard deviation of 10. Higher scores indicate more significant problems. Scores below 60 are within normal limits; 60-64: subclinical difficulties; 65-69: mildly elevated; 70-74: moderately elevated; and 75 or above: considered highly elevated, suggesting significant difficulties in emotion regulation. These questionnaires were administered at baseline (before intervention) and 3 months post-intervention. Because parent report may be less biased regarding youth's regulation, we used parent data for analysis. Data imputation was done for missing data.

Time frame:
18 weeks (from pre-intervention to 3-months after post-intervention)
Reported as:
Mean · T Score
Changes in Emotional Regulation
T ScorePathways for African-Americans' SuccessWait-list
Pre-intervention (baseline)54.43 ± 12.2352.02 ± 10.15
Post-intervention (3-month follow-up after 6-week intervention)54.47 ± 13.7460.77 ± 16.76
Statistical analysis
  • Pathways for African-Americans' Success vs Wait-list · Wilk's Lambda · p = 0.003 · Mean difference (final values): 9.40
SecondaryChanges in Cognitive Regulation

Cognitive regulation was assessed through parent and youth self-reported questionnaires using the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2). T scores, normed for age and sex are available. T-score standardizes an individual's executive functioning difficulties relative to peers. For example, 50 is the population mean and a standard deviation of 10. Higher scores indicate more significant problems. Scores below 60 are within normal limits; 60-64: subclinical difficulties; 65-69: mildly elevated; 70-74: moderately elevated; and 75 or above: considered highly elevated, suggesting significant difficulties in cognitive regulation. These questionnaires were administered at baseline (before intervention) and 3 months post-intervention. Because parent report may be less biased regarding youth's regulation, we used parent data for analysis. Data imputation was done for missing data.

Time frame:
18 weeks (from pre-intervention to 3-months after post-intervention)
Reported as:
Mean · T Score
Changes in Cognitive Regulation
T ScorePathways for African-Americans' SuccessWait-list
Pre-intervention (baseline)55.41 ± 10.7154.51 ± 10.52
post-intervention (3-month follow-up after intervention)51.81 ± 20.9455.66 ± 18.44
Statistical analysis
  • Pathways for African-Americans' Success vs Wait-list · Wilk's Lambda · p = 0.45 · Mean difference (final values): 0.566

Adverse events

Collected over Adverse events were collected from baseline (pre-treatment) visit until 3 months post-intervention visits. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pathways for African-Americans' Success0/86 (0%)0/86 (0%)0/86 (0%)
Wait-list0/60 (0%)0/60 (0%)0/60 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Pathways for African-Americans' SuccessWait-listTotal
<=18 years8660146
Between 18 and 65 years000
>=65 years000
Age, Continuous
Age, Continuous(Years)Pathways for African-Americans' SuccessWait-listTotal
Mean12.56 ± 1.012.57 ± 1.012.56 ± 1.0
Sex: Female, Male
Sex: Female, Male(Participants)Pathways for African-Americans' SuccessWait-listTotal
Female382664
Male483482
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Pathways for African-Americans' SuccessWait-listTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American8660146
White000
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Pathways for African-Americans' SuccessWait-listTotal
United States8660146
Emotion regulation
Emotion regulation(T score)Pathways for African-Americans' SuccessWait-listTotal
Mean54.43 ± 12.2352.02 ± 10.1553.44 ± 11.45
07

Study locations

1 site
  • University of California, Irvine
    Irvine, California 92617, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 29, 2016
  • Informed consent form · Dec 2, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03370393
Lead sponsor
University of California, Irvine
Collaborators
National Institute on Drug Abuse (NIDA)
Responsible party
Uma Rao (Professor, University of California, Irvine) — Principal investigator
First posted
Dec 12, 2017
Start date
Dec 11, 2017
Primary completion
Mar 31, 2025
Completion
Apr 10, 2025
Results posted
Jan 26, 2026
Last update
Jan 26, 2026

Study contacts

Uma Rao, MD
principal investigator · University of California, Irvine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion